---

Mitigating Psychosis

---

Review Article

Author Details : Sunil Chaudhry*

Volume : 2, Issue : 4, Year : 2020

Article Page : 102-107

https://doi.org/10.18231/j.jsas.2020.017

Suggest article by email

Get Permission

---

Abstract

Young males are more likely to experience first-episode psychosis, compared to women in the same age group. Prevalence of schizophrenia is 2.5/1000 and which seems to be the only disorder whose prevalence is consistent across cultures and over time. Genetic factors play an important role in the causation of schizophrenia; the risk of illness is approximately 10% for a first-degree relative and 3% for a second-degree relative. According to the American Psychiatric Association, second-generation (atypical) antipsychotics with the exception of clozapine are the agents of choice for first-line treatment of schizophrenia. Clozapine is not recommended because of its risk of agranulocytosis. A combination of antipsychotic showed an improvement in symptoms, but the side effects need to be monitored.

Keywords: Psychosis, Schizophrenia, Dopamine, Extrapyramidal symptoms, Cognitive impairment.

How to cite : Chaudhry S , Mitigating Psychosis. IP J Surg Allied Sci 2020;2(4):102-107

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.